跳至主要内容
临床试验/NL-OMON48979
NL-OMON48979已完成不适用

Study on Transfusion Effects in Preterm infants - STEP-trial

niversitair Medisch Centrum Groningen0 个研究点目标入组 67 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
67

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 11(—)

入选标准

  • - gestational age < 32 weeks
  • - before 7 days of age
  • - written informed consent by legal representative(s)

排除标准

  • - Chromosomal abnormality (e.g. trisomy 13, 18, 21)
  • - Perinatal asphyxia resulting in Apgar score (AS) < 5 at five minutes
  • - Major congenital malformations that increase the risk of death or adverse
  • neurodevelopmental outcome (congenital cerebral malformations, congenital heart
  • diseases excluding patent ductus arteriosus)
  • - Intraventricular and periventricular hemorrhage > grade 2 according to
  • Papile, prior to inclusion
  • - Diagnosis of NEC prior to inclusion
  • - Alloimmune hemolytic disease, sickle-cell disease or thalassemia
  • - Any received RBC transfusions prior to inclusion
  • - Inability to understand Dutch by the parents
  • - Parents expressing strong philosophical or religious objections to
  • transfusion

研究者

相似试验